Celcuity Inc. (CELC) stock

CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30

$64.32−2.73 (-4.07%)

Close on Nov 11, 2026Market cap $3.15BP/E –Yield –

Celcuity ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Celcuity has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?